AREA TWO BIOFUND HAS DISSOLVED EFFECTIVE 2024. WE ARE NO LONGER ACTIVE.
We are a collective of Cambridge/Boston-based PhD, MD, and MBA trainees motivated by value creation rooted in biotechnological innovation, known as the Area Two Bio Fund. The primary goals of the fund are long-term growth of capital and education in public investing and biotechnology of its partners.
We leverage our diverse expertise, ranging from engineering development to clinical translation to business implementation, to inform public investing decisions across biotechnology sectors and life sciences.
Disclaimers: The Fund does not offer investment advice. Materials and presentations do not constitute investment recommendations. Any investment involves considerable risk. Information provided may be out-of-date or inaccurate. Individual partners are not liable for capital losses incurred by the Area Two Bio Fund. Any past performance is not indicative of future results. Investing is risky. This is not an advertisement for securities.
Company Details
- Founded
- -
- Address
- 77 Massachusetts Ave, Cambridge,massachusetts 02139,united States
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Keywords
- New York.
- HQ
- Cambridge, Massachusetts
Area Two Bio Fund Questions
Area Two Bio Fund's LinkedIn profile is https://www.linkedin.com/company/area-two-bio-fund
Area Two Bio Fund's industry is
Investment Management
Area Two Bio Fund's top competitors are
Medina Partners,
Crocker Ventures, Llc,
Qral Group,
Arpelos Biosciences,
Braided Health,
82vs,
Noubio Inc,
Esya Labs,
Neonvest,
Sentriqs.
Area Two Bio Fund's categories are Investment Management
Area Two Bio Fund's founding year is 2021
